Surgery Partners, Inc. (NASDAQ:SGRY) Receives $27.11 Average Price Target from Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have earned an average recommendation of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $27.1111.

Several research firms recently commented on SGRY. Royal Bank Of Canada cut their price target on Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a report on Tuesday, November 11th. Weiss Ratings restated a “sell (e+)” rating on shares of Surgery Partners in a report on Monday, December 29th. UBS Group cut their target price on Surgery Partners from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Thursday, November 13th. Mizuho lowered their price target on shares of Surgery Partners from $22.00 to $19.00 and set an “outperform” rating on the stock in a research report on Thursday, December 18th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $36.00 price objective on shares of Surgery Partners in a report on Tuesday, October 7th.

Surgery Partners Trading Down 1.7%

Shares of SGRY stock opened at $15.63 on Friday. Surgery Partners has a fifty-two week low of $14.94 and a fifty-two week high of $26.16. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.72 and a current ratio of 1.88. The stock’s fifty day moving average is $15.99 and its two-hundred day moving average is $19.81. The firm has a market capitalization of $2.02 billion, a P/E ratio of -11.49 and a beta of 1.91.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Monday, November 10th. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). The business had revenue of $821.50 million during the quarter, compared to analyst estimates of $823.55 million. Surgery Partners had a negative net margin of 5.21% and a positive return on equity of 2.41%. Surgery Partners’s quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter last year, the company earned $0.19 earnings per share. Research analysts expect that Surgery Partners will post 0.67 earnings per share for the current fiscal year.

Institutional Trading of Surgery Partners

Hedge funds and other institutional investors have recently made changes to their positions in the company. Jones Financial Companies Lllp raised its position in shares of Surgery Partners by 313.1% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock valued at $27,000 after buying an additional 930 shares during the period. AlphaQuest LLC increased its stake in Surgery Partners by 94.4% during the second quarter. AlphaQuest LLC now owns 2,057 shares of the company’s stock worth $46,000 after acquiring an additional 999 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its position in Surgery Partners by 45,640.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock valued at $49,000 after purchasing an additional 2,282 shares during the period. PNC Financial Services Group Inc. lifted its stake in shares of Surgery Partners by 128.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 2,702 shares of the company’s stock valued at $58,000 after purchasing an additional 1,519 shares during the last quarter. Finally, FNY Investment Advisers LLC purchased a new position in shares of Surgery Partners during the 2nd quarter worth $115,000.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.